Literature DB >> 30793560

[Infantile spinal muscular atrophy : therapeutic (R)evolution].

A Daron1, S Delstanche2, T Dangouloff1, L Servais1,3.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder. The infantile form is the most common genetic cause of infantile death due to respiratory insufficiency. The disorder is caused by the premature death of motor neurons of anterior horn, leading to progressive weakness and muscular atrophy. Longtime considered as untreatable, the pathology knew a real revolution during the last two years. Views on this terrible disease have completely changed, changing, therefore, the management of the patients and constituting new challenges.

Entities:  

Keywords:  Newborn screening; Treatments ; Spinal muscular atrophy

Mesh:

Substances:

Year:  2019        PMID: 30793560

Source DB:  PubMed          Journal:  Rev Med Liege        ISSN: 0370-629X


  1 in total

1.  Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives.

Authors:  Tamara Dangouloff; Laurent Servais
Journal:  Ther Clin Risk Manag       Date:  2019-10-02       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.